ArticleClinical and molecular hepatology2024

Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.

Pei-Chien Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.